Scandinavian Real Heart AB (Publ)
Research Scandinavian Real Heart AB (Publ) (7820) on Bullrun: market cap EUR 13.51M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker7820
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 13.51M
- Financial periodQ2 2025
- RevenueSEK 0
- Net income-SEK 8.73M
- Free cash flow-SEK 8.57M
Valuation Snapshot
latest market cap is EUR 13.51M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 13.51M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Scandinavian Real Heart AB (Publ)
Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Scandinavian Real Heart AB (Publ)'s market cap?
Scandinavian Real Heart AB (Publ)'s market capitalization is EUR 13.51M.
What does Scandinavian Real Heart AB (Publ) do?
Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.